
Knight Therapeutics provides Medimetriks with $20mm loan to support OPA15406 transaction
Executive Summary
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Nonconvertible Debt
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com